Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status. Issue 14 (17th July 2016)

• Record Type: Journal Article
• Authors: Anwar, Tarique; Khosla, Sanjeev; Ramakrishna, Gayatri
• Is Part Of: Cell cycle. Volume 15:Issue 14(2016)
• Page Start: 1883
• Page End: 1897
• Publication Date: 2016-07-17
• Subjects: doxorubicin -- p53 -- senescence -- Sirtuins -- SIRT2; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2016.1189041
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: Sirtuins (SIRT) belonging to the NAD+ dependent histone deacetylase III class of enzymes have emerged as master regulators of metabolism and longevity. However, their role in prevention of organismal aging and cellular senescence still remains controversial. In the present study, we now report upregulation of SIRT2 as a specific feature associated with stress induced premature senescence but not with either quiescence or cell death. Additionally, increase in SIRT2 expression was noted in different types of senescent conditions such as replicative and oncogene induced senescence using multiple cell lines. Induction of SIRT2 expression during senescence was dependent on p53 status as depletion of p53 by shRNA prevented its accumulation. Chromatin immunoprecipitation revealed the presence of p53 binding sites on the SIRT2 promoter suggesting its regulation by p53, which was also corroborated by the SEAP reporter assay. Overexpression or knockdown of SIRT2 had no effect on stress induced premature senescence, thereby indicating that SIRT2 increase is not a cause of senescence; rather it is an effect linked to senescence-associated changes. Overall, our results suggest SIRT2 as a promising marker of cellular senescence at least in cells with wild type p53 status.